References
- Slavova S, Rock P, Bush HM, et al. Signal of increased opioid overdose during COVID-19 from emergency medical services data. Drug Alcohol Depend. 2020;214:108176.
- Opioid Overdoses: Drug Overdose Deaths. 2020.. In Centers for Disease Control and Prevention. Available from: https://www.cdc.gov/drugoverdose/data/statedeaths.html
- Hill MV, McMahon ML, Stucke RS, et al. Wide variation and excessive dosage of opioid prescriptions for common general surgical procedures. Ann Surg. 2017;265(4):709–714.
- Brummett CM, Waljee J, Goesling J, et al. New persistent opioid use after minor and major surgical procedures in US adults. JAMA Surg. 2017;152(6):e170504.
- Clark H, Soneji N, Ko DT, et al. Rates and risk factors for prolonged opioid use after major surgery: population based cohort study. BMJ. 2014;348:g1251.
- Wright EA, Katz JN, Abrams S, et al. Trends in prescription of opioids from 2003–2009 in persons with knee osteoarthritis. Arthritis Care Res. 2014;66(10):1489–1495.
- Brummett CM, England C, Evans-Shields J, et al. Health care burden associated with outpatient opioid use following inpatient or outpatient surgery. JMCP. 2019;25(9):973–983.
- Asche CV, Dagenais A, Kang A, et al. Impact of liposomal bupivacaine on opioid use, hospital length of stay, discharge status, and hospitalization costs in patients undergoing total hip arthroplasty. J Med Econ. 2019;22(12):1253–1260.
- Asche CV, Dagenais A, Kang A, et al. Impact of treatment with liposomal bupivacaine on hospital costs, length of stay, and discharge status in patients undergoing total knee arthroplasty at high-use institutions. J Med Econ. 2019;22(1):85–94.
- Mont MA, Beaver WB, Dysart SH, et al. Local infiltration analgesia with liposomal bupivacaine improves pain scores and reduces opioid use after total knee arthroplasty: results of a randomized controlled trial. J Arthroplasty. 2018;33(1):90–96.
- Suskind AM, Zhang Y, Dunn RL, et al. Understanding the diffusion of ambulatory surgery centers. Surg Innov. 2015;22(3):257–265.
- 2019 National Healthcare Quality and Disparities Report. (2021). In Agency for Healthcare Research and Quality. Available from: https://www.ahrq.gov/research/findings/nhqrdr/nhqdr19/index.html
- ERAS Compliance Group. The impact of enhanced recovery protocol compliance on elective colorectal cancer resection: results from an international registry. Ann Surg. 2015;261:1153–1159.
- Messenger DE, Curtis NJ, Jones A, et al. Factors predicting outcome from enhanced recovery programmes in laparoscopic colorectal surgery: a systematic review. Surg Endosc. 2017;31(5):2050–2071.
- Ahmed J, Khan S, Lim M, et al. Enhanced recovery after surgery protocols – compliance and variations in practice during routine colorectal surgery. Colorectal Dis. 2012;14(9):1045–1051.
- Feroci F, Lenzi E, Baraghini M, et al. Fast-track surgery in real life: how patient factors influence outcomes and compliance with an enhanced recovery clinical pathway after colorectal surgery. Surg Laparosc Endosc Percutan Tech. 2013;23(3):259–265.
- Thorn CC, White I, Burch J, et al. Active and passive compliance in an enhanced recovery programme. Int J Colorectal Dis. 2016;31(7):1329–1339.
- McNeil BJ. Shattuck lecture-hidden barriers to improvement in the quality of care. N Engl J Med. 2001;345(22):1612–1620.